A model for predicting gestational diabetes mellitus in early pregnancy: a prospective study in Thailand
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: To develop a predictive model using the risk factors of gestational diabetes mellitus (GDM) and construct a predictive nomogram for GDM risk in women during early pregnancy. Methods: A prospective study was conducted in two tertiary hospitals among pregnant women with gestational age ≤14 weeks. Early GDM was diagnosed if an abnormal 100 g oral glucose tolerance test was detected using the Carpenter and Coustan criteria after an abnormal 50 g glucose challenge test. The factors included in the model were ACOG risk factors; maternal age; family history of hypertensive disorder in pregnancy; family history of dyslipidemia; gravida; parity; histories of preterm birth, early fetal death, abortion, stillbirth, and low birth weight; and glycated hemoglobin (HbA1c) levels. The predictive models for early GDM were analyzed using multiple logistic regression analyses. The nomograms were constructed, and their discrimination ability and predictive accuracy were tested. Results: Of the 553 pregnant women, 54 (9.8%) were diagnosed with early GDM. In the integrated model, there was a history of GDM (adjusted odds ratio [aOR], 5.15; 95% confidence interval [CI], 1.82-14.63; P=0.004), HbA1c threshold ≥5.3% (aOR, 2.61; 95% CI, 1.44-4.74; P=0.002), and family history of dyslipidemia (aOR, 2.68; 95% CI, 1.37-5.21; P=0.005). The integrated nomogram model showed that a history of GDM had a high impact on the risk of early GDM. Its discrimination and mean absolute error were 0.76 and 0.009, respectively. Conclusion: Application of the predictive model and nomogram will help healthcare providers investigate the probability of early GDM, especially in resource-limited countries.
Abstract
Objective: To develop a predictive model using the risk factors of gestational diabetes mellitus (GDM) and construct a predictive nomogram for GDM risk in women during early pregnancy. Methods: A prospective study was conducted in two tertiary hospitals among pregnant women with gestational age ≤14 weeks. Early GDM was diagnosed if an abnormal 100 g oral glucose tolerance test was detected using the Carpenter and Coustan criteria after an abnormal 50 g glucose challenge test. The factors included in the model were ACOG risk factors; maternal age; family history of hypertensive disorder in pregnancy; family history of dyslipidemia; gravida; parity; histories of preterm birth, early fetal death, abortion, stillbirth, and low birth weight; and glycated hemoglobin (HbA1c) levels. The predictive models for early GDM were analyzed using multiple logistic regression analyses. The nomograms were constructed, and their discrimination ability and predictive accuracy were tested. Results: Of the 553 pregnant women, 54 (9.8%) were diagnosed with early GDM. In the integrated model, there was a history of GDM (adjusted odds ratio [aOR], 5.15; 95% confidence interval [CI], 1.82-14.63; P=0.004), HbA1c threshold ≥5.3% (aOR, 2.61; 95% CI, 1.44-4.74; P=0.002), and family history of dyslipidemia (aOR, 2.68; 95% CI, 1.37-5.21; P=0.005). The integrated nomogram model showed that a history of GDM had a high impact on the risk of early GDM. Its discrimination and mean absolute error were 0.76 and 0.009, respectively. Conclusion: Application of the predictive model and nomogram will help healthcare providers investigate the probability of early GDM, especially in resource-limited countries.
참고문헌 (40)
- American Diabetes Association, "(2)Classification and diagnosis of diabetes", Diabetes Care, 38(Suppl 1), pp.S8~S16 (2015)
- Buchanan TA, "Gestational diabetes mellitus", J Clin Invest, 115, pp.485~491 (2005)
- "Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period" (2015)[URL]
- "ACOG practice bulletin No. 190: gestational diabetes mellitus", Obstet Gynecol, 131, pp.e49~e64 (2018)
- American Diabetes Association, "2. Classification and diagnosis of diabetes", Diabetes Care, 40(Suppl 1), pp.S11~S24 (2017)
- "Global prevalence of gestational diabetes mellitus: a systematic review and meta-analysis" (2020)[URL]
- Boriboonhirunsarn D, "Incidence of gestational diabetes mellitus diagnosed before 20 weeks of gestation", J Med Assoc Thai, 87, pp.1017~1021 (2004)
- Immanuel J, "Screening and treatment for early-onset gestational diabetes mellitus : a systematic review and meta-analysis", Curr Diab Rep, 17, pp.115~ (2017)
- US Preventive Services Task Force, "Screening for gestational diabetes : US preventive services task force recommendation statement", JAMA, 326, pp.531~538 (2021)
- Utz B, "“Why screen if we cannot followup and manage?” Challenges for gestational diabetes screening and management in low and lower-middle income countries: results of a cross-sectional survey", BMC Pregnancy Childbirth, 16, pp.341~ (2016)
- American Diabetes Association, "Standards of medical care in diabetes--2011", Diabetes Care, 34(Suppl 1(Suppl 1)), pp.S11~S61 (2011)
- Amaefule CE, "The accuracy of haemoglobin A1c as a screening and diagnostic test for gestational diabetes : a systematic review and meta-analysis of test accuracy studies", Curr Opin Obstet Gynecol, 32, pp.322~334 (2020)
- Phaloprakarn C, "Risk assessment for preeclampsia in women with gestational diabetes mellitus", J Perinat Med, 37, pp.617~621 (2009)
- Savvidou M, "First-trimester prediction of gestational diabetes mellitus : examining the potential of combining maternal characteristics and laboratory measures", Diabetes, 59, pp.3017~3022 (2010)
- Arbib N, "First trimester glycosylated hemoglobin as a predictor of gestational diabetes mellitus", Int J Gynaecol Obstet, 145, pp.158~163 (2019)
- Boriboonhirunsarn D, "Prevalence of early-onset GDM and associated risk factors in a university hospital in Thailand", J Obstet Gynaecol, 41, pp.915~919 (2021)
- Carpenter MW, "Criteria for screening tests for gestational diabetes", Am J Obstet Gynecol, 144, pp.768~773 (1982)
- World Health Organization, "WHO STEPS surveillance manual: the WHO STEP wise approach to chronic disease risk factor surveillance", World Health Organization, ~ (2005)
- Armstrong T, "Development of the World Health Organization global physical activity questionnaire(GPAQ)", J Public Health, 14, pp.66~70 (2006)
- López-Ratón M, "OptimalCutpoints : an R package for selecting optimal cutpoints in diagnostic tests", J Stat Soft, 61, pp.1~36 (2014)
- Steyerberg EW, "Prediction models need appropriate internal, internal-external, and external validation", J Clin Epidemiol, 69, pp.245~247 (2016)
- "rms:regression modeling strategies. R package version 6.0-0 2020" (2020)[URL]
- Wu YT, "Early prediction of gestational diabetes mellitus in the Chinese population via advanced machine learning", J Clin Endocrinol Metab, 106, pp.e1191~e1205 (2021)
- American Diabetes Association, "2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021", Diabetes Care, 44(Suppl 1), pp.S15~S33 (2021)
- "ACOG Practice Bulletin No. 190: gestational diabetes mellitus", Obstet Gynecol, 131, pp.e49~e64 (2018)
- Liu ZY, "Glucose screening within six months postpartum among Chinese mothers with a history of gestational diabetes mellitus : a prospective cohort study", BMC Pregnancy Childbirth, 19, pp.134~ (2019)
- Fong A, "Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus", Am J Obstet Gynecol, 211, pp.641.e1~641.e7 (2014)
- Osmundson SS, "First trimester hemoglobin A1c prediction of gestational diabetes", Am J Perinatol, 33, pp.977~982 (2016)
- Siricharoenthai P, "Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus", J Matern Fetal Neonatal Med, 33, pp.3497~3500 (2020)
- Ryckman KK, "Maternal lipid levels during pregnancy and gestational diabetes : a systematic review and metaanalysis", BJOG, 122, pp.643~651 (2015)
- O’Malley EG, "Maternal obesity and dyslipidemia associated with gestational diabetes mellitus(GDM)", Eur J Obstet Gynecol Reprod Biol, 246, pp.67~71 (2020)
- van Leeuwen M, "Estimating the risk of gestational diabetes mellitus : a clinical prediction model based on patient characteristics and medical history", BJOG, 117, pp.69~75 (2010)
- Adam S, "Selective screening strategies for gestational diabetes : a prospective cohort observational study", J Diabetes Res, 2017, pp.2849346~ (2017)
- Guo F, "Nomogram for prediction of gestational diabetes mellitus in urban, Chinese, pregnant women", BMC Pregnancy Childbirth, 20, pp.43~ (2020)
- Souza ACRLA, "Can we stratify the risk for insulin need in women diagnosed early with gestational diabetes by fasting blood glucose?", J Matern Fetal Neonatal Med, 32, pp.2036~2041 (2019)
- Li W, "Nomograms for incident risk of post-partum type 2 diabetes in Chinese women with prior gestational diabetes mellitus", Clin Endocrinol(Oxf), 90, pp.417~424 (2019)
- Lappharat S, "Accuracy of screening tests for gestational diabetes mellitus in Southeast Asia: a systematic review of diagnostic test accuracy studies", Medicine(Baltimore), 99, pp.e23161~ (2020)
- Glaharn P, "Proportion of abnormal second 50-g glucose challenge test in gestational diabetes mellitus screening using the two-step method in high-risk pregnant women", J Obstet Gynaecol Res, 46, pp.229~236 (2020)
- Nathalie Jeanne Magioli Bravo-Valenzuela, "Fetal cardiac function by mitral and tricuspid annular plane systolic excursion using spatio-temporal image correlation M‐mode and left cardiac output in fetuses of pregestational diabetic mothers", Obstetrics & Gynecology Science, 64(3), pp.257~265 (2021), 대한산부인과학회[DOI]
- 이경희, "Treatment of gestational diabetes diagnosed by the IADPSG criteria decreases excessive fetal growth", Obstetrics & Gynecology Science, 63(1), pp.19~26 (2020), 대한산부인과학회[DOI]